[Chemotherapy of colonic cancer].
Block
Sylvie
S
Centre hospitalier de Valenciennes. block.s@ch-valenciennes.fr
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D000069287:Capecitabine; D003110:Colonic Neoplasms / Q000188:drug therapy*; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D018450:Disease Progression; D066246:ErbB Receptors / Q000276:immunology; D005472:Fluorouracil / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D002955:Leucovorin / Q000009:adverse effects / Q000627:therapeutic use; D009944:Organoplatinum Compounds / Q000009:adverse effects / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D000964:Antimetabolites, Antineoplastic; D009944:Organoplatinum Compounds; D003841:Deoxycytidine; D000069287:Capecitabine; D066246:ErbB Receptors; D002955:Leucovorin; D005472:Fluorouracil